BCLS SB Investco, LP - 19 Feb 2025 SCHEDULE 13D/A Report for Solid Biosciences Inc. Common Stock, $0.001 par value per share (SLDB)

Filing Manager
BCLS SB Investco, LP
Reporting Manager
BCLS II Investco, LP
Security
Solid Biosciences Inc. Common Stock, $0.001 par value per share
Symbol
SLDB
Shares outstanding
79,218,487 shares
Disclosed Ownership
6,179,042 shares
Ownership
7.8%
Form type
SCHEDULE 13D/A
Filing time
21 Feb 2025, 18:04:54 UTC
Date of event
19 Feb 2025
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BCLS SB Investco, LP 0.7% 528,660 0 528,660 /s/ Adam Koppel Adam Koppel, Partner of Bain Capital Life Sciences Investors, LLC 0001728056
Bain Capital Life Sciences Fund II, L.P. 0.3% 267,257 0 267,257 /s/ Adam Koppel Adam Koppel, Partner of Bain Capital Life Sciences Investors, LLC 0001773187
BCLS II Investco, LP 7.8% 6,179,042 0 6,179,042 /s/ Adam Kopppel Adam Koppel, Partner of Bain Capital Life Sciences Investors, LLC 0001818893
BCIP Life Sciences Associates, LP 0.04% 32,550 0 32,550 /s/ Adam Koppel Adam Koppel, authorized signatory of Boylston Coinvestors, LLC 0001702921
BCLS II Equity Opportunities, LP 1.1% 904,160 0 904,160 /s/ Adam Koppel Adam Koppel, Partner of Bain Capital Life Sciences Investors, LLC 0001814474